SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AXYS Pharmaceuticals Inc.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (450)3/8/2001 1:12:32 PM
From: Mike McFarland   of 455
 
biz.yahoo.com
...in the process of planning to advance the
compound to Phase IIb/III clinical studies.

...The Company expects that work to further
define the development track for APC 2059 and
to delay initiation of clinical trials for
APC 2059 until next year.

That may be why Mr. Market marking down AXPH
today--I've not yet listened to the call.

Axys issues year 2000 report, induces rectal
bleeding in shareholders.
Free tissue paper and 2059 at annual meeting.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News